Guideline for the Diagnosis and Treatment of Helicobacter Pylori Infection with the Integrated Traditional Chinese and Western Medicine

Title: Guideline for the Diagnosis and Treatment of Helicobacter Pylori Infection with the Integrated Traditional Chinese and Western Medicine
Edition: Original
Classification: Traditional Chinese Medicine guideline
Field: Diagnosis and Treatment
Countries and regions: China
Guidelines users: This standard is applicable to the standardized integrated traditional Chinese and Western medicine diagnosis and treatment of Helicobacter pylori infection by clinical practitioners of traditional Chinese medicine and integrated traditional Chinese and Western medicine; Suitable for researchers to further explore the pathological mechanism and drug development of this disease, and strengthen their understanding of the disease; It is also available for senior medical students and medical enthusiasts to read and learn.
Evidence classification method: The GRADE standard is used to evaluate the quality of the evidence body, determine the level of evidence, form the GRADE evidence summary table and evidence summary table, and archive the formed evidence summary table and evidence summary table in the form of attachments.
Development unit: Beijing Hospital of Traditional Chinese Medicine, Capital Medical University
Registration time: 2024-09-29
Registration number: PREPARE-2024CN696
Purpose of the guideline: In recent years, there has been significant progress in the diagnostic criteria, eradication indications, and traditional Chinese and Western medicine treatment of H. pylori infection. Clinical and basic research on traditional Chinese medicine eradication of H. pylori has also achieved certain results. Through continuous practice and summarization in clinical practice, the role of traditional Chinese medicine in treating H. pylori infection has been further clarified. The formulation of this consensus has significant practical significance for the prevention and treatment of H. pylori related diseases in China, reflecting the overall goal and advantages of integrating traditional Chinese and Western medicine in the treatment of H. pylori at the current stage.